591 related articles for article (PubMed ID: 27834739)
41. Regulation of Normal and Malignant Hematopoiesis by FBOX Ubiquitin E3 Ligases.
Hynes-Smith RW; Wittorf KJ; Buckley SM
Trends Immunol; 2020 Dec; 41(12):1128-1140. PubMed ID: 33160841
[TBL] [Abstract][Full Text] [Related]
42. Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox.
Siepe DH; Picton LK; Garcia KC
ACS Synth Biol; 2023 Apr; 12(4):1081-1093. PubMed ID: 37011906
[TBL] [Abstract][Full Text] [Related]
43. E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology.
Michaelides IN; Collie GW
J Med Chem; 2023 Mar; 66(5):3173-3194. PubMed ID: 36821822
[TBL] [Abstract][Full Text] [Related]
44. A microarray of ubiquitylated proteins for profiling deubiquitylase activity reveals the critical roles of both chain and substrate.
Loch CM; Strickler JE
Biochim Biophys Acta; 2012 Nov; 1823(11):2069-78. PubMed ID: 22626734
[TBL] [Abstract][Full Text] [Related]
45. Regulation of E3 ubiquitin ligases by homotypic and heterotypic assembly.
Balaji V; Hoppe T
F1000Res; 2020; 9():. PubMed ID: 32076548
[TBL] [Abstract][Full Text] [Related]
46. Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer.
Eisenberg-Lerner A; Ciechanover A; Merbl Y
Exp Biol Med (Maywood); 2016 Aug; 241(14):1475-82. PubMed ID: 27229346
[TBL] [Abstract][Full Text] [Related]
47. Therapeutic strategies within the ubiquitin proteasome system.
Eldridge AG; O'Brien T
Cell Death Differ; 2010 Jan; 17(1):4-13. PubMed ID: 19557013
[TBL] [Abstract][Full Text] [Related]
48. Diggin' on u(biquitin): a novel method for the identification of physiological E3 ubiquitin ligase substrates.
Rubel CE; Schisler JC; Hamlett ED; DeKroon RM; Gautel M; Alzate O; Patterson C
Cell Biochem Biophys; 2013 Sep; 67(1):127-38. PubMed ID: 23695782
[TBL] [Abstract][Full Text] [Related]
49. Ubiquitination and E3 Ubiquitin Ligases in Rare Neurological Diseases with Comorbid Epilepsy.
Zhu J; Tsai NP
Neuroscience; 2020 Jan; 428():90-99. PubMed ID: 31931110
[TBL] [Abstract][Full Text] [Related]
50. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
[TBL] [Abstract][Full Text] [Related]
51. Role of E3 ubiquitin ligases in insulin resistance.
Yang XD; Xiang DX; Yang YY
Diabetes Obes Metab; 2016 Aug; 18(8):747-54. PubMed ID: 27097743
[TBL] [Abstract][Full Text] [Related]
52. Conventional and unconventional ubiquitination in plant immunity.
Zhou B; Zeng L
Mol Plant Pathol; 2017 Dec; 18(9):1313-1330. PubMed ID: 27925369
[TBL] [Abstract][Full Text] [Related]
53. Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets.
Shi D; Grossman SR
Cancer Biol Ther; 2010 Oct; 10(8):737-47. PubMed ID: 20930542
[TBL] [Abstract][Full Text] [Related]
54. Specificity and disease in the ubiquitin system.
Chaugule VK; Walden H
Biochem Soc Trans; 2016 Feb; 44(1):212-27. PubMed ID: 26862208
[TBL] [Abstract][Full Text] [Related]
55. From
Cabana VC; Lussier MP
Cells; 2022 Jan; 11(3):. PubMed ID: 35159190
[TBL] [Abstract][Full Text] [Related]
56. The ubiquitin-proteasome system in melanin metabolism.
Shi J; Guo Y; Wang H; Xiao Y; Liu W; Lyu L
J Cosmet Dermatol; 2022 Dec; 21(12):6661-6668. PubMed ID: 36207998
[TBL] [Abstract][Full Text] [Related]
57. Up-regulation of ubiquitin-proteasome activity upon loss of NatA-dependent N-terminal acetylation.
Kats I; Reinbold C; Kschonsak M; Khmelinskii A; Armbruster L; Ruppert T; Knop M
Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34764209
[TBL] [Abstract][Full Text] [Related]
58. The Multifaceted Role of the Ubiquitin Proteasome System in Pathogenesis and Diseases.
Stekel Z; Sheng Y; Zhang W
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883481
[TBL] [Abstract][Full Text] [Related]
59. Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function.
Potjewyd FM; Axtman AD
Front Cell Neurosci; 2021; 15():768655. PubMed ID: 34867205
[TBL] [Abstract][Full Text] [Related]
60. Non-canonical ubiquitin-based signals for proteasomal degradation.
Kravtsova-Ivantsiv Y; Ciechanover A
J Cell Sci; 2012 Feb; 125(Pt 3):539-48. PubMed ID: 22389393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
